NaturalProductMech

sirolimus

CHEBI:9168 EXACT SEEDED antibacterialcytotoxicenzyme inhibitor

A macrolide lactam isolated from Streptomyces hygroscopicus consisting of a 29-membered ring containing 4 trans double bonds, three of which are conjugated. It is an antibiotic, immunosupressive and antineoplastic agent.

Structure

Standard InChIKeyQFJCIRLUMZQUOT-HPLJOQBZSA-N
SMILES[H][C@@]12CC[C@@H](C)[C@@](O)(O1)C(=O)C(=O)N1CCCC[C@@]1([H])C(=O)O[C@@]([H])(CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C2)OC)[C@H](C)C[C@@H]1CC[C@@H](O)[C@@H](C1)OC
Stereochemistryfully defined
Cross-referencesnpatlas:NPA0414, pubchem:5284616

Filing pathway

Polyketides — computed by NPClassifier npclassifier.gnps2.org@2026-09-07, which is why it is pinned rather than recomputed. The gene cluster's asserted class is nrps, pks, from MIBiG.

Producer organisms 1

A claim that this taxon makes the compound. The basis says what the evidence addressed — a knockout and a database assertion are not the same claim.

TaxonBasisClusterEvidence
Streptomyces rapamycinicus NRRL 5491
NCBITaxon:1343740
SOURCE_ASSERTION mibig:BGC0001040 PMID:7644502

Occurrences 25

Somebody found the compound in this organism and cited it. That is not a claim that the organism makes it, and nothing here promotes one to the other.

TaxonSourceReference
Purpureocillium
NCBITaxon:1052105
LOTUS DOI:10.1021/ACS.JNATPROD.0C00404
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1007/BF01573954
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1007/S00253-011-3348-6
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1007/S00449-013-1051-Y
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1016/0378-1119(95)00799-7
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1016/B978-0-12-404634-4.00017-6
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1016/J.JBIOSC.2013.03.011
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1016/S0006-291X(03)01231-2
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1016/S0378-1119(97)00450-2
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1038/SJ.JIM.2900434
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1074/JBC.RA118.005314
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1099/13500872-142-10-2815
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1099/13500872-145-8-1989
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1099/MIC.0.28194-0
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1111/J.1432-1033.1997.00526.X
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.1128/GENOMEA.00616-14
Streptomyces rapamycinicus
NCBITaxon:1226757
LOTUS DOI:10.4014/JMB.1403.03024
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1007/BF01573954
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1007/S00253-011-3348-6
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1007/S00449-013-1051-Y
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1016/0378-1119(95)00799-7
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1016/B978-0-12-404634-4.00017-6
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1016/J.JBIOSC.2013.03.011
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1016/S0006-291X(03)01231-2
Streptomyces hygroscopicus
NCBITaxon:1912
LOTUS DOI:10.1016/S0378-1119(97)00450-2

Biosynthetic gene clusters 1

AccessionHostLocus evidenceGenome
mibig:BGC0001040 Streptomyces rapamycinicus NRRL 5491
NCBITaxon:1343740
CLUSTER_UNSTATED genbank:X86780.1

A locus claim and a taxon claim are different questions. Heterologous expression settles the first and leaves the second where the isolation report left it.

Causal graph — bioactivity 4 nodes, 4 edges

Sirolimus binds human FKBP12 and the FKBP12-sirolimus complex binds the human mTOR FKBP12-rapamycin-binding domain.

SubjectPredicateObjectEvidence
sirolimus binds human FKBP12 DOI:10.1016/1074-5521(95)90264-3
sirolimus forms human FKBP12-sirolimus complex DOI:10.1016/1074-5521(95)90264-3
human FKBP12 forms human FKBP12-sirolimus complex DOI:10.1126/science.273.5272.239
human FKBP12-sirolimus complex binds human mTOR FRB domain DOI:10.1126/science.273.5272.239

Every edge carries its own citation; an uncited edge is refused by the corpus tests.

Bioactivities 25

AssayResultReference
A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.33.4983 uMpubchem.aid:624296
A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.33.4983 uMpubchem.aid:624297
Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDBKD 0.0002 uMpubchem.aid:977611
Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDBKI 0.0009 uMpubchem.aid:977610
FKBP12 Assay from Article 10.1016/1074-5521(95)90264-3: "Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface."KI 0.001 uMPMID:9383449
Inhibitors of USP1/UAF1: Pilot qHTS35.4813 uMpubchem.aid:504865
Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation1.5101 uMpubchem.aid:504832
Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation1.5101 uMpubchem.aid:504834
S16 Schwann cell viability assay (CellTiter-Glo assay)0.0256 uMpubchem.aid:624031
SPR Assay to Determine Binding Affinity to FKBP12 from US Patent US11603377: "MTORC1 modulators and uses thereof"KD 0.0003 uMpubchem.aid:1919337
SPR Assay to Determine Binding Affinity to FKBP51 from US Patent US11603377: "MTORC1 modulators and uses thereof"KD 0.01 uMpubchem.aid:1919338
VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity31.6228 uMpubchem.aid:2546
qHTS for Inhibitors of TGF-b12.5893 uMpubchem.aid:588855
qHTS for Inhibitors of TGF-b: Cytotox Counterscreen35.4813 uMpubchem.aid:588856
qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT8.9125 uMpubchem.aid:686978
qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT4.4668 uMpubchem.aid:686979
qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS10 uMpubchem.aid:720580
qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS8.9125 uMpubchem.aid:720579
qHTS for inhibitors of ROR gamma transcriptional activity35.4813 uMpubchem.aid:2551
qHTS of alpha-syn Inhibitors3.9811 uMpubchem.aid:652106
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose DatabaseACTIVEpubchem.aid:1195
Experimentally measured binding affinity data derived from PDBACTIVEpubchem.aid:1811
Experimentally measured binding affinity data derived from PDBACTIVEpubchem.aid:1811
Expression of GFP-tagged protein in TOR C1 bypass strains and wild type Saccharomyces cerevisiaeACTIVEpubchem.aid:504479
Expression of GFP-tagged protein in TOR C1 bypass strains and wild type Saccharomyces cerevisiaeACTIVEpubchem.aid:504479

Elsewhere in the fleet

Open questions 1

name-disagreement — ChEBI calls this structure 'sirolimus' and MIBiG calls it 'rapamycin'. They share a Standard InChIKey, so if the names denote different compounds then one upstream record has the wrong structure. Check which.

Provenance

Source conceptSourceVersion
BGC0001040MIBIG5
CHEBI:9168CHEBI3-star

This page is generated from data/natural_products/polyketides/sirolimus.yaml, which is generated from the committed inventories. Neither is edited by hand.